The inaugural NA-ATTC dissemination event ‘Reflections on Advanced Therapy Delivery in the NHS’ took place in Newcastle upon Tyne on the 21May19. The day explored the ATMP delivery story so far, focusing on the CAR T journey from development through to adoption into the NHS. Key speakers included clinicians, pharmacists, regulatory experts and Advanced Therapy developers who between them shared a wealth of knowledge on the learning points and challenges of delivering this exciting and innovative class of medicines to patients.
The event was a great success, with over 100 delegates in attendance and some excellent presentations, workshops and discussion. Our particular thanks go to the speakers for sharing their time, insight and expertise, as well as our AHSN NENC colleagues who provided outstanding support in organising the event.
Please click on the links below to view presentations:
Professor Andrew Webster- Institutional Readiness for Advanced Therapies
Dr Will Horsley- Commissioning Perspective- Advanced Therapy Medicinal Products
Dr Tobias Menne- Reflection on CAR T-cell Delivery in the NHS
Dr Panos Kefalas- Reimbursement Considerations for ATMPs
Dr Erin Hurst- JACIE Inspection Process
Dr Alan Macdonald- SMC Requirements for Advanced Therapy Medicinal Product Provision
Dean Bradley- Cellular Therapy Operational Considerations NAATTC
Anne Black- ATMPs Governance Aspects Alan Runacus- Building Logistics Platforms
Alan Runacus- Building Logistics Platforms
Steve Williamson- Commissioning for Advanced Therapy Medicinal Products- NHS England Perspective
Dr Suzy O’Neill- CAR T- Safety Considerations
Dr Sheila Waugh- GMSC Considerations
